Intrinsic Value Partners, LLC Ironwood Pharmaceuticals Inc Transaction History
Intrinsic Value Partners, LLC
- $92.5 Million
- Q2 2024
A detailed history of Intrinsic Value Partners, LLC transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Intrinsic Value Partners, LLC holds 45,435 shares of IRWD stock, worth $188,555. This represents 0.32% of its overall portfolio holdings.
Number of Shares
45,435
Previous 47,745
4.84%
Holding current value
$188,555
Previous $415,000
28.67%
% of portfolio
0.32%
Previous 0.46%
Shares
11 transactions
Others Institutions Holding IRWD
# of Institutions
247Shares Held
170MCall Options Held
11.2MPut Options Held
28.5K-
Black Rock Inc. New York, NY22.9MShares$94.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA21.6MShares$89.5 Million0.0% of portfolio
-
Sarissa Capital Management LP Greenwich, CT16.4MShares$68 Million18.04% of portfolio
-
State Street Corp Boston, MA9.24MShares$38.4 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA8.91MShares$37 Million0.15% of portfolio
About IRONWOOD PHARMACEUTICALS INC
- Ticker IRWD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 153,231,008
- Market Cap $636M
- Description
- Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...